Calithera Biosciences Stock Price Patterns
| CALA Stock | USD 0.0002 0.0001 100.00% |
Momentum 37
Sell Extended
Oversold | Overbought |
Using Calithera Biosciences hype-based prediction, you can estimate the value of Calithera Biosciences from the perspective of Calithera Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Calithera Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Calithera because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Calithera Biosciences after-hype prediction price | USD 8.2E-5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Calithera |
Calithera Biosciences After-Hype Price Density Analysis
As far as predicting the price of Calithera Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Calithera Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Calithera Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Calithera Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Calithera Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Calithera Biosciences' historical news coverage. Calithera Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 43.97, respectively. We have considered Calithera Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Calithera Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Calithera Biosciences is based on 3 months time horizon.
Calithera Biosciences Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Calithera Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Calithera Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Calithera Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
4.48 | 43.97 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0002 | 0.000082 | 18.25 |
|
Calithera Biosciences Hype Timeline
Calithera Biosciences is currently traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Calithera is expected to decline in value after the next headline, with the price expected to drop to 8.2E-5. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -18.25%, whereas the daily expected return is currently at 4.48%. The volatility of related hype on Calithera Biosciences is about 9558695.65%, with the expected price after the next announcement by competition of 0.00. About 27.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Calithera Biosciences recorded a loss per share of 1.59. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 15th of June 2022. Given the investment horizon of 90 days the next expected press release will be in 5 to 10 days. Check out Calithera Biosciences Basic Forecasting Models to cross-verify your projections.Calithera Biosciences Related Hype Analysis
Having access to credible news sources related to Calithera Biosciences' direct competition is more important than ever and may enhance your ability to predict Calithera Biosciences' future price movements. Getting to know how Calithera Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Calithera Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IVBT | Innovation1 Biotech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TLOG | TetraLogic Pharmaceuticals Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ARNI | Arno Therapeutics | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 | |
| TNGNQ | Tengion | 0.00 | 4 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BXRXQ | Baudax Bio | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BTTX | Better Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KLDO | Kaleido Biosciences | 0.00 | 1 per month | 0.00 | 0.12 | 0.00 | 0.00 | 4,998 | |
| PANC | Panacos Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SCIE | Spectrascience New | 0.01 | 1 per month | 0.84 | 0.01 | 1.45 | (2.05) | 8.40 | |
| ONPH | Oncology Pharma | (0.01) | 1 per month | 22.28 | 0.16 | 150.00 | (50.00) | 1,990 |
Calithera Biosciences Additional Predictive Modules
Most predictive techniques to examine Calithera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Calithera using various technical indicators. When you analyze Calithera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Calithera Biosciences Predictive Indicators
The successful prediction of Calithera Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Calithera Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Calithera Biosciences based on analysis of Calithera Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Calithera Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Calithera Biosciences's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Calithera Pink Sheet analysis
When running Calithera Biosciences' price analysis, check to measure Calithera Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calithera Biosciences is operating at the current time. Most of Calithera Biosciences' value examination focuses on studying past and present price action to predict the probability of Calithera Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calithera Biosciences' price. Additionally, you may evaluate how the addition of Calithera Biosciences to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |